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Abstract
Background: Light exposure and more specifically the spectrum of blue light contribute to the oxidative stress in
Age-related macular degeneration (AMD). The purpose of the study was to establish whether blue light filtering
could modify proangiogenic signaling produced by retinal pigmented epithelial (RPE) cells under different
conditions simulating risk factors for AMD.
Methods: Three experiments were carried out in order to expose ARPE-19 cells to white light for 48 h with and
without blue light-blocking filters (BLF) in different conditions. In each experiment one group was exposed to light
with no BLF protection, a second group was exposed to light with BLF protection, and a control group was not
exposed to light. The ARPE-19 cells used in each experiment prior to light exposure were cultured for 24 h as
follows: Experiment 1) Normoxia, Experiment 2) Hypoxia, and Experiment 3) Lutein supplemented media in
normoxia. The media of all groups was harvested after light exposure for sandwich ELISA-based assays to quantify
10 pro-angiogenic cytokines.
Results: A significant decrease in angiogenin secretion levels and a significant increase in bFGF were observed
following light exposure, compared to dark conditions, in both normoxia and hypoxia conditions. With the addition
of a blue light-blocking filter in normoxia, a significant increase in angiogenin levels was observed. Although
statistical significance was not achieved, blue light filters reduce light-induced secretion of bFGF and VEGF to near
normal levels. This trend is also observed when ARPE-19 cells are grown under hypoxic conditions and when pre-
treated with lutein prior to exposure to experimental conditions.
Conclusions: Following light exposure, there is a decrease in angiogenin secretion by ARPE-19 cells, which was
abrogated with a blue light - blocking filter. Our findings support the position that blue light filtering affects the
secretion of angiogenic factors by retinal pigmented epithelial cells under normoxic, hypoxic, and lutein-pretreated
conditions in a similar manner.
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Background
Age-related macular degeneration (AMD) is the leading
cause of severe and irreversible loss of vision in the elderly
in developed countries [1]. AMD is a complex disease as-
sociated with many environmental, lifestyle, and genetic
factors [2–4]. Although some aspects of AMD pathogen-
esis are not well understood, there is a growing body of
evidence suggesting that oxidative stress can contribute to
the onset and progression of the condition [5]. A known
cause of such oxidative stress is exposure to short wave-
length light, including ultraviolet and blue light.
Blue light exposure has been linked to abnormal secre-
tion of potent pro-angiogenic factors that can promote
the onset or progression of ocular diseases with a neo-
vascular component. The blue light spectrum of natural
sunlight is often cited as the primary cause of blue light-
induced damage within the eye. Indeed, data from epide-
miologic analyses support this hypothesis: the Beaver
Dam Eye Study and the Chesapeake Bay Waterman
Study both reported a significant association between
cumulative sunlight exposure and AMD [6–9]. More-
over, it has been demonstrated that blue light-induced
damage in retinal pigmented epithelial (RPE) cells can
promote angiogenic signaling, thereby contributing to an
environment that promotes neovascular disease [10].
The mounting evidence that blue light exposure may
contribute to the development of AMD has led to the
introduction of blue light-filtering intraocular lenses
(IOLs) as an alternative to traditional IOL models. Previ-
ous studies have shown that blue light-filtering IOLs can
mitigate light-induced increases in vascular endothelial
growth factor (VEGF) compared with IOLs that only fil-
ter ultraviolet (UV) light [11, 12].
The local environment in the macula of patients with
non-exudative AMD is known to be hypoxic [13]. More-
over, aging in general has been associated with inflamma-
tion and hypoxia in the choriocapillaris, RPE layer, and
neurosensory retina [14]. Hypoxia may also be caused by
confluent drusen— characteristic feature of AMD —,
which can increase the distance between Bruch’s mem-
brane and the RPE and neural retina, thereby impeding
oxygen delivery to the latter [4, 15, 16].
Lutein is a well described, naturally occurring macular
pigment; high levels of lutein in the macula are known to
be protective against AMD [17, 18]. A number of studie-
s—including the Age-Related Eye Disease Study 2
(AREDS2), a large-scale clinical trial—have demonstrated
that lutein supplementation may be protective against
progression from AMD to a more severe stage of the dis-
ease [19]. Recommendations on the heels of AREDS2 have
led many clinicians to advise high-risk AMD patients to
consume lutein-containing supplements.
Several studies suggest that filtering blue light may re-
duce oxidative stress and angiogenic signaling in the retina
[10–12]; however, whether or not the consequences of
such filtering would be altered by a hypoxic environ-
ment—such as that seen in the eyes of some AMD
patients—are unknown. Similarly, it is not known whether
lutein supplementation in high-risk non-exudative AMD
patients can alter the well-studied benefits of blue light fil-
tering in AMD patients. Accordingly, the purpose of the
current study was to establish the degree to which blue
light filtering could affect angiogenic signaling in RPE cells
under normoxic, hypoxic, and lutein-treated conditions.
Methods
Three experiments were carried out in order to expose
ARPE-19 cells to white light with and without blue light-
blocking filters (BLF) in different conditions (normoxia,
hyperoxia and lutein pre-treated). Each experiment had one
group exposed to light with a BLF protection, a second
group exposed to light with no filter protection, and a light-
unexposed control group. The ARPE-19 cells used in each
experiment prior to light exposure were cultured for 24 h,
as described below. The media of all groups was harvested
after light exposure to quantify pro-angiogenic cytokines.
Cell culture
The ARPE-19 cell line was obtained from American Type
Culture Collection (Manassas, VA, USA). Cells were incu-
bated at 37 °C in a humidified 5% CO2-enriched atmos-
phere, and cultured in a 1:1 mixture of Dulbecco’s
modified Eagle’s medium (DMEM) and Ham’s F12
medium (ThermoFisher, MA, USA) supplemented with
10% fetal bovine serum (FBS), 1% fungizone, and 1%
penicillin-streptomycin. Normal growth was confirmed at
every media change by phase contrast microscopy. Cul-
tures were grown to confluence and subcultured using
0.05% trypsin in EDTA (Corning Inc., NY, USA). ARPE-19
cells at passage seven were used in all experiments.
Cells were seeded on 48-well plates at a density of
2.5 × 104 cells/well for all experiments and grown in
complete media overnight. The following day, cells were
serum-starved and incubated for an additional 24 h in
normoxia (experiment 1), hypoxia (experiment 2) or pre-
treated with Lutein (experiment 3). Cells were then ex-
posed to light with or without filter. The control plate was
wrapped in aluminum foil (dark maintained), while the
other two plates were left unwrapped under a light source
(light exposed). Supernatants from duplicate wells were
pooled and experiments were conducted in triplicate.
Experimental conditions
Experiment 1: Normoxic conditions - Cells were seeded
and the following day were serum-starved and incubated
under normoxic conditions (37 °C, 5% CO2) for an add-
itional 24 h before being exposed to light for 48 h.
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Experiment 2: Hypoxic conditions - ARPE-19 cell cul-
tures were serum-starved for 24 h and then incubated in
1% O2. Hypoxia was induced using a Modular Incubator
Chamber (Billups-Rothenberg, Inc., San Diego, CA,
USA) before being exposed to light. The hypoxic mix-
ture of the certified medical pre-mixed gas used was:
1.00% O2, 4.98% CO2 and balance N2.
Experiment 3: Pre-treatment with lutein - Serum-free 1:1
DMEM:Ham’s F12 media supplemented with lutein crystals
(Sigma-Aldrich, St. Louis, MO, USA) was prepared. Lutein
crystals were dissolved in 0.05% dichloromethane solution
at a final concentration of 1 μg/mL, as described in the lit-
erature [19]. ARPE-19 cell cultures were serum-starved for
24 h and then pre-treated with lutein-supplemented media.
The following day were exposed to light.
Light source and blue light filter setup
Controlled exposure of RPE cells to white light was
achieved using a cell culture incubator that enabled the in-
stallation of a fixed light source (white light LED,
NSSW157AT, Nichia Corporation, Japan). In order to set
up the third treatment condition, a blue light filter (BLF)
(R4590, Roscolux, USA; 98% blocking at 450 nm) was
placed between the cell culture plate and the light source.
The intensity of light reaching the surface of the cell cul-
ture plates was then measured using a luxometer and
found to be an average of 9000 lx (range: 8800–9200 lx).
In the group exposed to white light without a BLF, a series
of transparent filters were used to reduce the intensity of
light at the surface of cell culture plates to within the
range measured for the group with the BLF.
Angiogenesis arrays
Quantification of angiogenic cytokines within the collected
supernatant was performed as per the manufacturer’s in-
structions using the Quantibody Human Angiogenesis
Array 1 kit (RayBiotech Inc., Norcross, GA, USA), which is
based on a sandwich enzyme-linked immunosorbent assay-
based system. The array allows for the simultaneous quanti-
fication of the following 10 pro-angiogenic cytokines:
angiogenin, ANG-2, EGF, bFGF, HB-EGF, PDGF-BB, Lep-
tin, PIGF, HGF, and VEGF-A. Briefly, protein secretion
levels of the angiogenic cytokines within the samples were
analyzed by comparing the intensities of the fluorescent sig-
nals produced with the standard curve generated by stand-
ard samples in each array. Concentrations were reported in
picograms per milliliter (pg/mL). A step-by-step method-
ology of this process has previously been described by our
group [20].
Statistical analysis
Shapiro-Wilk test was used to assess normal distributions
in the levels of angiogenic factors and comparisons were
performed with the Student’s t-test or Wilcoxon rank sum
test, as appropriate. For comparison of two experimental
groups, an unpaired, two-sample Welch’s t-test was used.
To compare the three experimental groups, the nonpara-
metric Kruskal-Wallis test was used, followed by Dunn’s
post hoc test to calculate the p-value for each group.
Graphs show the mean ± standard error of the mean
(SEM); statistical significance was defined as p < 0.05. All
analyses were performed using GraphPad Prism statistical
software (GraphPad Software, Inc., San Diego, CA, USA).
Results
The effect of white light exposure on the secretion of
angiogenic cytokines by ARPE-19 cells was determined
in three experiments. Only three of the ten cytokines an-
alyzed were above the lower limit of detection for the
assay, namely angiogenin, bFGF, and VEGF.
On the first experiment, a significant (p < 0.05) decrease
was observed in angiogenin secretion levels following white
light exposure (compared to dark conditions). Increases in
both bFGF and VEGF were observed when RPE cells were
exposed to white light compared to dark conditions (nor-
moxia); however, only the increase in bFGF was significant
(p < 0.05). The effect of blue light filtering was also
assessed. A significant (p < 0.05) increase in angiogenin
levels was observed within supernatant samples collected
from RPE cells exposed to white light with a BLF, compared
to samples collected from RPE cells exposed to white light
without a BLF. Light-induced secretion of bFGF was de-
creased in RPE cells exposed to white light in the presence
of a BLF compared to cells exposed to white light alone;
however, this finding was not statistically significant. Al-
though a slight decrease in VEGF levels was observed with
blue light filtering compared to white light exposure, this
decrease was also not statistically significant (Fig. 1).
On the second experiment, it was determined whether
the effects of BLFs on the secretion of angiogenin, bFGF,
and VEGF were maintained under hypoxic conditions.
As seen under normoxic conditions, a significant
(p < 0.05) decrease in angiogenin levels was observed
upon white light exposure compared to dark conditions.
A slight increase in angiogenin levels was seen when
RPE cells were exposed to white light with a BLF; how-
ever, this was not found to be significant. In addition, a
decrease in light-induced bFGF and VEGF secretion was
observed with blue light filtering; however, these findings
were also statistically insignificant (Fig. 2).
On the third experiment, the effect of blue light filter-
ing was also assessed when the cells under normoxic
conditions were pre-treated with lutein. Trends in the
secretion of angiogenin, bFGF, and VEGF following lu-
tein pretreatment were similar to those observed when
RPE cells were grown under hypoxic and normoxic con-
ditions; however, none of the trends were found to be
significant (Fig. 3).
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Discussion
In the present study, we investigated the effects of blue
light filtering on the secretion profile of proangiogenic
cytokines by RPE cells. To the best of our knowledge,
this is the first study to demonstrate that following light
exposure, angiogenin secretion by RPE cells is decreased,
and this decrease is abrogated with a blue light filter.
We also demonstrated that, although not significant, this
trend is maintained when RPE cells are grown under
hypoxic conditions and when pre-treated with lutein.
Although the etiology of AMD is not well understood,
there is strong evidence indicating that retinal hypoxia
plays a significant role in retinal neovascularization [21,
22]. On the other hand, lutein-containing supplements
have been found to be beneficial and protective in slow-
ing the progression of AMD [23–26]. We therefore
sought to determine whether the effects of blue light fil-
tering are maintained when RPE cells are exposed to
hypoxic conditions or when pre-treated with lutein. We
focused our investigation on angiogenin, VEGF, and
bFGF given that their secretion was found to be above
the limit of detection as indicated by our array system.
Fig. 1 Experiment 1: Light exposure under normoxia - Secretion of
angiogenin, bFGF, and VEGF by RPE cells in the dark, or under white-light
exposure, with or without a blue light filter. A significant (p < 0.05)
decrease in angiogenin secretion was observed under white-light
exposure when compared to dark conditions and a significant (p < 0.05)
increase in bFGF secretion was observed under white light exposure
when compared to dark conditions. However, although VEGF secretion
was increased under white light exposure, this increase was not found to
be statistically significant. Analyses were conducted using Welch’s
unpaired t test. When assessing the effect of a blue light filter
on the secretion of angiogenic factors following white light
exposure, a significant (p < 0.05) increase was observed in
angiogenin secretion levels. Although bFGF and VEGF levels
were decreased in the presence of a blue light filter, this
decrease was not statistically significant. (NS: non significant;
* = P ≤ 0.05; ** ≤0.01)
Fig. 2 Experiment 2: Light exposure under hypoxia - Secretion levels
of angiogenin, bFGF, and VEGF from supernatant samples of RPE
cells grown under hypoxic conditions in the dark, or under white
light with or without a blue light filter. Trends in the secretion of
angiogenin, bFGF, and VEGF under hypoxic conditions were similar
to those observed under normoxic conditions; however, none of the
trends were found to be significant. (NS: non significant;
* = P ≤ 0.05; ** ≤0.01)
Fig. 3 Experiment 3: Light exposure under normoxia when
pretreament with lutein - Secretion levels of angiogenin, bFGF, and
VEGF from supernatant with or without a blue light filter. Trends in
the secretion of angiogenin, bFGF, and VEGF following lutein
pretreatment were similar to those observed when RPE cells were
grown under hypoxic and normoxic conditions; however, none of
the trends were found to be significant. A slight increase in
angiogenin levels was seen when RPE cells were exposed to white
light with a BLF; however, this result was not found to be significant.
In addition, decreases in light-induced bFGF and VEGF secretion
were observed with blue light filtering; however, these decreases
were also insignificant. (NS: non significant; * = P ≤ 0.05; ** ≤0.01)
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The role of angiogenin in the aging eye and in choroidal
neovascularization is poorly understood. One study evalu-
ating the histopathologic secretion of angiogenin in post-
mortem control and AMD donor eyes noted similar secre-
tion patterns, however no conclusive statement can be
reached given the small sample size of three AMD eyes
used in the analyses [27]. Results from studies assessing
angiogenin levels in other ocular malignancies, namely
diabetic retinopathy (DR), have been contradicting. Marek
et al. (2011) described an inverse relationship in the con-
centrations of VEGF and angiogenin in patients with DR
[28]. The authors observed a decrease in angiogenin and
an increase in VEGF concentrations in both serum and
vitreous samples from patients with DR compared to
healthy individuals [28]. This is in accordance with our re-
sults demonstrating an inverse relationship between VEGF
and angiogenin secretion levels following light exposure.
Our group has also previously demonstrated an upregula-
tion in angiogenin secretion with an expected abrogation
in VEGF secretion following anti-VEGF treatment of RPE
cells [20]. Our combined results support the hypothesis of
a compensatory mechanism that is likely activated in re-
sponse to decreased VEGF levels. To the best of our
knowledge, this is the first report describing the differen-
tial secretion of angiogenin by RPE cells in response to a
blue-light filter in vitro. Additional studies evaluating the
secretion pattern of angiogenin in normal and AMD eyes,
and the mechanisms underlying its down-regulation by
RPE cells following light exposure are required.
Our results also demonstrated that blue light filters
prevent light-induced up-regulation of bFGF and VEGF
secretion to near normal levels. Although not significant,
this trend is also observed when RPE cells are grown
under hypoxic conditions and when pre-treated with lu-
tein prior to exposure to experimental conditions. Un-
like angiogenin, the proangiogenic effects of VEGF and
bFGF in ocular neovascularization are well documented
in the literature [12, 29–33]. It is also well established
that VEGF and bFGF levels are increased in hypoxic
conditions as a means of promoting neovascularization
of ischemic tissues [34–36]. Our data on VEGF secretion
are in accordance with previous reports demonstrating
VEGF up-regulation by RPE cells following light expos-
ure and its inhibition when cells are cultured with a blue
light-filtering intraocular lens [37].
A recent study by Kishimoto et al. (2005) was first to de-
scribe the interplay between VEGF, bFGF, and angiogenin
[38]. The authors demonstrated the important role that
angiogenin plays in mediating VEGF- and bFGF-induced
angiogenesis. Specifically, the authors showed that angio-
genin is indeed required for VEGF and bFGF to stimulate
angiogenesis [38]. In our study, we observed no changes
compared to control in light-induced secretion of VEGF
and bFGF with a blue light filter; however, there was a
concomitant increase in angiogenin production. Thus, we
hypothesize that RPE cells increase angiogenin secretion as
a means to compensate for the protective effects of blue
light filters. As anti-VEGF therapy is the gold standard
treatment for neovascular AMD, it may be of value to fur-
ther investigate the effect of anti-VEGF treatment on angio-
genin secretion and action in the eye.
The detrimental effects of blue light on the viability of
RPE cells are well documented in vitro and in vivo [39–44].
Blue light filters have been shown to protect RPE cells from
light-induced damage and apoptosis in RPE cell cultures
[10, 11, 45]. To the best of our knowledge, this the first
study investigating the secretion of pro-angiogenic cyto-
kines by blue-light exposed RPE cells under normoxia, hyp-
oxia, and lutein-pretreated conditions. Our findings
complement the growing body of evidence on the protect-
ive effects of blue light filtering IOLs, and suggest that these
benefits may be maintained even when patients have dry
AMD and are consuming lutein-containing supplements. It
should be noted that the current study is not without limi-
tations, and the previous statements require confirmation
through additional in vitro and in vivo studies. For one, the
light source used in our study yielded a range of light inten-
sity albeit narrow, and may not mimic life-long exposure to
blue light. Experts differ as to the exact wavelength of blue
light; therefore it is difficult to be accurate when intending
to block this specific wavelength range. Despite utilizing a
yellow filter almost selective in blocking blue light, we must
assume that minimal percentage of green light was also
blocked, which we recognize as a limiting factor of our
study. Another limitation of our study is the total number
of replicates that may have prevented the attainment of sta-
tistically significant data points.
Conclusions
Our findings support the position that blue light filtering
affects the secretion of angiogenic factors by RPE cells
under normoxic, hypoxic, and lutein-pretreated condi-
tions in a similar manner. These results support growing
evidence on the protective effects of blue light filtering
IOLs and suggest that blocking effect on the blue wave-
length light may be a benefit in patients with non-
exudative AMD, also when consuming lutein-containing
supplements. The cellular responses of RPE cells follow-
ing blue light exposure warrants further investigation.
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